Silence Therapeutics SLN
NASDAQ SLN
$10.64 -0.07 (-0.65%)
At close: Oct 2, 2026 · 4:00 PM EDT

Silence Therapeutics (SLN) Selling, General & Administrative (2024 - 2026)

Updated

Silence Therapeutics' Selling, General & Administrative was $4.72 million in the quarter ended Jun 30, 2026, down 8.1% from $5.13 million a year earlier and down 32.9% from the prior quarter.

Analysis

Silence Therapeutics (SLN) Selling, General & Administrative (2024 - 2026) Analysis & Trends

On a trailing twelve-month basis, Silence Therapeutics' Selling, General & Administrative was $21.27 million through Jun 30, 2026, down 18.4% year-over-year; for the year ended Dec 31, 2025, it came in at $22.34 million, down 16.9% from the prior year.

  • Selling, General & Administrative shows a five-year compound annual growth rate of 4.5% (years ended Dec 2020 to Dec 2025).
  • In earlier years, Selling, General & Administrative was $26.88 million in the year ended Dec 31, 2024 (+2.5%), $26.22 million in the year ended Dec 31, 2023 (+2.1%), $25.68 million in the year ended Dec 31, 2022 (-6.7%) and $27.53 million in the year ended Dec 31, 2021 (+53.3%).
  • Quarterly Selling, General & Administrative has moved between $3.73 million (the quarter ended Dec 31, 2025) and $7.7 million (the quarter ended Sep 30, 2024) over five years.
  • Compared with a year earlier, Selling, General & Administrative has declined for five straight quarters, with an average decline of 14.2% over the last six quarters.
  • Per Business Quant data, SLN's Selling, General & Administrative in the three quarters before the quarter ended Jun 30, 2026 was $7.03 million (quarter ended Mar 31, 2026), $3.73 million (quarter ended Dec 31, 2025) and $5.8 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 6.43 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.63 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -5.65 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.92 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 3.41 Bn
10 Silence Therapeutics 502.70 Mn 430.60 Mn - 4.72 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.72 Mn
Mar 31, 2026 7.03 Mn
Dec 31, 2025 3.73 Mn
Sep 30, 2025 5.80 Mn
Jun 30, 2025 5.13 Mn
Mar 31, 2025 7.68 Mn
Dec 31, 2024 5.54 Mn
Sep 30, 2024 7.70 Mn
Jun 30, 2024 7.01 Mn
Mar 31, 2024 6.64 Mn
API Access

Silence Therapeutics Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=SLN&period=max&api_key=YOUR_API_KEY